Frauenärztliche Gemeinschaftspraxis
Industry / private company
Location:
Braunschweig,
Germany (DE)
ISNI: -
CA27.29 as a tumour marker for risk evaluation and therapy monitoring in primary breast cancer patients (2016)
Rack B, Jueckstock J, Trapp E, Weissenbacher T, Alunni-Fabbroni M, Schramm A, Widschwendter P, et al.
Journal article
Toxicity Assessment of a Phase III Study Evaluating FEC-Doc and FEC-Doc Combined with Gemcitabine as an Adjuvant Treatment for High-Risk Early Breast Cancer: the SUCCESS-A Trial (2016)
Schroeder L, Rack B, Sommer H, Koch JG, Weissenbacher T, Janni W, Schneeweiss A, et al.
Journal article